Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2003 June;47(2)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2)

 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):77-84

Advanced ovarian carcinoma: usefulness of [18F]FDG-PET in combination with CT for lesion detection after primary treatment

Picchio M., Sironi S., Messa C., Mangili G., Landoni C., Gianolli L., Zangheri B., Viganò R., Aletti G. De Marzi P., De Cobelli F., Del Maschio A., Ferrari A., Fazio F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):85-9

Paraneoplastic syndromes: detection of malignant tumors using [18F]FDG-PET

Berner U., Menzel C., Rinne D., Kriener S., Hamscho N., Döbert N., Diehl M., Kaufmann R., Grünwald F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):90-100

Evaluation of the clinical performances of a large NaI(Tl) crystal 3D PET scanner

Picchio M., Savi A., Lecchi M., Landoni C., Gianolli L., Brioschi M., Rossetti C., Gilardi M. C., Fazio F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):101-8

Hodgkin’s disease. Prognostic value of Gallium-67 scintigraphy

Hervás I., Segura A., López-Tendero P., Bello P., González-Cabezas P., Flores D., Yuste A., Pérez-Velasco R., Girones R., Mateo A.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):109-15

Is there a role for 99mTc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?

Fuster D., Maurel J., Muxí A., Setoain X., Ayuso C., Martín F., Ortega M. L., Fuertes S., Pons F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):116-28

The role of 99mTc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection

Spanu A., Tanda F., Dettori G., Manca A., Chessa F., Porcu A., Falchi A., Nuvoli S., Madeddu G.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):129-38

Importance of radio-guided minimally invasive parathyroidectomy using hand-held γ probe and low 99mTc-MIBI dose. Technical considerations and long-term clinical results

Rubello D., Casara D., Giannini S., Piotto A., De Carlo E., Muzzio P. C., Pelizzo M. R.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):139-44

Radioimmuno targetting technetium 99mlabeled anti-epidermal growth factor receptor monoclonal antibody in experimental tumor models

Meenakshi A., Ganesh V., Suresh Kumar R., Siva Kumar N.


top of page